Stryker (SYK) Stock Price, News & Analysis

Company Overview

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Key Stats

• Today's Range: $363.28 to $368.51
• 50-Day Range: $363.52 to $399.83
• 52-Week Range: $314.93 to $406.19
• Volume: 1.27 million shs
• Average Volume: 1.29 million shs
• Market Capitalization: $139.08 billion
• P/E Ratio: 46.96
• Dividend Yield: 0.92%
• Price Target: $421.90
• Consensus Rating: Moderate Buy

Stryker Stock Analysis - MarketRank™

Stryker scored higher than 95% of companies evaluated by MarketBeat, and ranked 42nd out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 16 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Stryker has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 10.10%

Earnings Growth

Earnings for Stryker are expected to grow by 10.10% in the coming year, from $13.47 to $14.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stryker is 46.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.58.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stryker is 46.96, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.58.

Price to Earnings Growth Ratio

Stryker has a PEG Ratio of 2.93. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stryker has a P/B Ratio of 6.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.49% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently increased by 12.26%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Stryker has a dividend yield of 0.91%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Stryker has been increasing its dividend for 32 years.

Dividend Coverage

The dividend payout ratio of Stryker is 43.30%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Stryker will have a dividend payout ratio of 22.66% next year. This indicates that Stryker will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -0.95

Percentage of Shares Shorted

1.49% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently increased by 12.26%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.48

News Sentiment

Stryker has a news sentiment score of 1.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 48 news articles for Stryker this week, compared to 21 articles on an average week.

Search Interest

Only 7 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -81% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -64% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $79,935,584.00 in company stock.

Percentage Held by Insiders

Only 5.90% of the stock of Stryker is held by insiders.

Percentage Held by Institutions

77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SYK Stock Analysis - Frequently Asked Questions

How have SYK shares performed this year?

Stryker's stock was trading at $360.05 at the start of the year. Since then, SYK stock has increased by 1.2% and is now trading at $364.3810.
View the best growth stocks for 2025 here.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) posted its quarterly earnings results on Tuesday, January, 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a trailing twelve-month return on equity of 23.58% and a net margin of 13.25%.
Read the conference call transcript.

Does Stryker have any subsidiaries?

The following companies are subsidiaries of Stryker: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others.

Who are Stryker's major shareholders?

Top institutional investors of Stryker include Vanguard Group Inc. (8.58%), Greenleaf Trust (4.65%), Price T Rowe Associates Inc. MD (2.91%) and Wellington Management Group LLP (2.20%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein.
View institutional ownership trends.

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

• Record date for 1/31 Dividend: 12/31/2024
• Ex-Dividend for 1/31 Dividend: 12/31/2024
• Last Earnings: 1/28/2025
• Dividend Payable: 1/31/2025
• Today: 3/30/2025
• Record date for 4/30 Dividend: 3/31/2025
• Ex-Dividend for 4/30 Dividend: 3/31/2025
• Next Earnings (Estimated): 4/29/2025
• Dividend Payable: 4/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SYK
• CIK: 310764
• Web: www.strykercorp.com
• Phone: (269) 385-2600
• Fax: 269-385-1062
• Employees: 53,000
• Year Founded: 1941

Price Target and Rating

• Average Stock Price Target: $421.90
• High Stock Price Target: $450.00
• Low Stock Price Target: $370.00
• Potential Upside/Downside: +15.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 20 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $7.76
• Trailing P/E Ratio: 46.96
• Forward P/E Ratio: 27.05
• P/E Growth: 2.93
• Net Income: $2.99 billion
• Net Margins: 13.25%
• Pretax Margin: 15.45%
• Return on Equity: 23.58%
• Return on Assets: 11.37%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 1.95
• Quick Ratio: 1.32

Sales & Book Value

• Annual Sales: $22.60 billion
• Price / Sales: 6.16
• Cash Flow: $14.22 per share
• Price / Cash Flow: 25.62
• Book Value: $54.08 per share
• Price / Book: 6.74

Miscellaneous

• Outstanding Shares: 381,689,000
• Free Float: 359,066,000
• Market Cap: $139.08 billion
• Optionable: Optionable
• Beta: 0.95